Jean-Philippe Rigaud

Dr. Jean-Philippe Rigaud

1. Intensive Care Unit, Dieppe Hospital, Dieppe, France
+1

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2022 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
GPGaël Piton
Gaël Piton
AGAmélie Le Gouge
Amélie Le Gouge
JBJulie Boisrame-Helms
Julie Boisrame-Helms
NANadia Anguel
Nadia Anguel
LALaurent Argaud
Laurent Argaud
TGthe Clinical Research in Intensive Care and Sepsis (CRICS) group
the Clinical Research in Intensive Care and Sepsis (CRICS) group

16 March 2010 in Critical Care
Verified
Journal Article
Open access
PDF file
JQJean-Pierre Quenot
Jean-Pierre Quenot
GPGaetan Plantefeve
Gaetan Plantefeve
JBJean-Luc Baudel
Jean-Luc Baudel
ICIsabelle Camilatto
Isabelle Camilatto
EBEmmanuelle Bertholet
Emmanuelle Bertholet
JRJean-Philippe Rigaud
Jean-Philippe Rigaud
Introduction: The primary aim was to measure the amount of nutrients required, prescribed and actually administered in critically ill patients. Secondary aims were to assess adherence to clinical practice guidelines, and investigate factors leading to non-adherence. Methods: Observational, multicenter, prospective study, including 203 patients in a total of 19 intensive care units in France. The prescribed calorie supply was compared with the theoretical minimal required calorie intake (25 Kcal/Kg/day) and with the supply actually delivered to the patient to calculate the ratio of calories prescribed/required and the ratio of calories delivered/prescribed. Clinical factors suspected to influence enteral nutrition were analyzed by univariate and multivariate analysis. Results: The median ratio of prescribed/required calories per day was 43 [37-54] at day 1 and increased until day 7. From day 4 until the end of the study, the median ratio was > 80%. The median ratio of delivered/prescribed per day was > 80% for all 7 days from the start of enteral nutrition. Among the variables tested (hospital type, use of a local nutrition protocol, sedation, vasoactive drugs, number of interruptions of enteral nutrition and measurement of gastric residual volume), only measurement of residual volume was significant by univariate analysis. This was confirmed by multivariate analysis, where gastric residual volume measurement was the only variable independently associated with the ratio of delivered/prescribed calories (OR = 1.38; 95%CI, 1.12-2.10, p = .024). Conclusions: The translation of clinical research and recommendations for enteral nutrition into routine bedside practice in critically ill patients receiving mechanical ventilation was satisfactory, but could probably be improved with a multidisciplinary approach.

23 December 2014 in Trials
Verified
Journal Article
Open access
PDF file
LBLaurent Brisard
Laurent Brisard
AGAmélie Le Gouge
Amélie Le Gouge
JLJean Baptiste Lascarrou
Jean Baptiste Lascarrou
HDHerve Dupont
Herve Dupont
PAPierre Asfar
Pierre Asfar
JRJean Reignier
Jean Reignier
Nutritional support is crucial to the management of patients receiving invasive mechanical ventilation (IMV) and the most commonly prescribed treatment in intensive care units (ICUs). International guidelines consistently indicate that enteral nutrition (EN) should be preferred over parenteral nutrition (PN) whenever possible and started as early as possible. However, no adequately designed study has evaluated whether a specific nutritional modality is associated with decreased mortality. The primary goal of this trial is to assess the hypothesis that early first-line EN, as compared to early first-line PN, decreases day 28 all-cause mortality in patients receiving IMV and vasoactive drugs for shock. The NUTRIREA-2 study is a multicenter, open-label, parallel-group, randomized controlled trial comparing early PN versus early EN in critically ill patients requiring IMV for an expected duration of at least 48 hours, combined with vasoactive drugs, for shock. Patients will be allocated at random to first-line PN for at least 72 hours or to first-line EN. In both groups, nutritional support will be started within 24 hours after IMV initiation. Calorie targets will be 20 to 25 kcal/kg/day during the first week, then 25 to 30 kcal/kg/day thereafter. Patients receiving PN may be switched to EN after at least 72 hours in the event of shock resolution (no vasoactive drugs for 24 consecutive hours and arterial lactic acid level below 2 mmol/L). On day 7, all patients receiving PN and having no contraindications to EN will be switched to EN. In both groups, supplemental PN may be added to EN after day 7 in patients with persistent intolerance to EN and inadequate calorie intake. We plan to recruit 2,854 patients at 44 participating ICUs. The NUTRIREA-2 study is the first large randomized controlled trial designed to assess the hypothesis that early EN improves survival compared to early PN in ICU patients. Enrollment started on 22 March 2013 and is expected to end in November 2015. ClinicalTrials.gov Identifier: NCT01802099 (registered 27 February 2013)

26 April 2021 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
OLOlivier Lesieur
Olivier Lesieur
JQJean-Pierre Quenot
Jean-Pierre Quenot
ZCZoé Cohen-Solal
Zoé Cohen-Solal
RDRaphaëlle David
Raphaëlle David
LBLaure De Saint Blanquat
Laure De Saint Blanquat
JRJean-Philippe Rigaud
Jean-Philippe Rigaud
Intensive care unit professionals have experience in critical care and its proportionality, collegial decision-making, withholding or withdrawal of treatment deemed futile, and communication with patients’ relatives. These elements rely on ethical values from which we must not deviate in a pandemic situation. The recommendations made by the Ethics Commission of the French Intensive Care Society reflect an approach of responsibility and solidarity towards our citizens regarding the potential impact of a pandemic on critical care resources in France, with the fundamental requirement of respect for human dignity and equal access to health care for all.

1 April 2016 in Journal of Critical Care
Verified
Journal Article
Closed access
JRJean-Philippe Rigaud
Jean-Philippe Rigaud
JHJean-Baptiste Hardy
Jean-Baptiste Hardy
NMNicolas Meunier-Beillard
Nicolas Meunier-Beillard
HDHervé Devilliers
Hervé Devilliers
FEFiona Ecarnot
Fiona Ecarnot
JQJean-Pierre Quenot
Jean-Pierre Quenot

17 June 2023 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
MDMaxime Desgrouas
Maxime Desgrouas
JDJulien Demiselle
Julien Demiselle
LSLaure Stiel
Laure Stiel
VBVincent Brunot
Vincent Brunot
RMRémy Marnai
Rémy Marnai
TBThierry Boulain
Thierry Boulain
Hyperglycaemia is common in critically ill patients, but blood glucose and insulin management may differ widely among intensive care units (ICUs). We aimed to describe insulin use practices and the resulting glycaemic control in French ICUs. We conducted a multicentre 1-day observational study on November 23, 2021, in 69 French ICUs. Adult patients hospitalized for an acute organ failure, severe infection or post-operative care were included. Data were recorded from midnight to 11:59 p.m. the day of the study by 4-h periods. Two ICUs declared to have no insulin protocol. There was a wide disparity in blood glucose targets between ICUs with 35 different target ranges recorded. In 893 included patients we collected 4823 blood glucose values whose distribution varied significantly across ICUs (P < 0.0001). We observed 1135 hyperglycaemias (> 1.8 g/L) in 402 (45.0%) patients, 35 hypoglycaemias (≤ 0.7 g/L) in 26 (2.9%) patients, and one instance of severe hypoglycaemia (≤ 0.4 g/L). Four hundred eight (45.7%) patients received either IV insulin (255 [62.5%]), subcutaneous (SC) insulin (126 [30.9%]), or both (27 [6.6%]). Among patients under protocolized intravenous (IV) insulin, 767/1681 (45.6%) of glycaemias were above the target range. Among patients receiving insulin, short- and long-acting SC insulin use were associated with higher counts of hyperglycaemias as assessed by multivariable negative binomial regression adjusted for the propensity to receive SC insulin: incidence rate ratio of 3.45 (95% confidence interval [CI] 2.97–4.00) (P < 0.0001) and 3.58 (95% CI 2.84–4.52) (P < 0.0001), respectively. Practices regarding blood glucose management varied widely among French ICUs. Administration of short or long-acting SC insulin was not unusual and associated with more frequent hyperglycaemia. The protocolized insulin algorithms used failed to prevent hyperglycaemic events.